Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Solid organ transplantation and gut microbiota: a review of the potential immunomodulatory properties of short-chain fatty acids in graft maintenance.
Front Cell Infect Microbiol
March 2024
National Institute of Health and Medical Research (FRANCE) (INSERM), Univ. Limoges, Pharmacology & Transplantation, U1248, Limoges, France.
Transplantation is the treatment of choice for several end-stage organ defects: it considerably improves patient survival and quality of life. However, post-transplant recipients may experience episodes of rejection that can favor or ultimately lead to graft loss. Graft maintenance requires a complex and life-long immunosuppressive treatment.
View Article and Find Full Text PDFTwenty years' experience of laparoscopic 1-anastomosis gastric bypass: surgical risk and long-term results.
Surg Obes Relat Dis
May 2021
Department of International Business, Chien Hsin University, Taoyuan, Taiwan.
Background: Laparoscopic 1- (single-) anastomosis gastric bypass (OAGB) was developed as a simplified technique of Roux-en-Y gastric bypass (RYGB), but super long-term data are lacking.
Objectives: To evaluate the risks and long-term results of OAGB over a period of 20 years.
Setting: Tertiary teaching hospital.
Malignancies following lung transplantation.
Transplant Proc
October 2007
Department of Thoracic Surgery, University of Rome La Sapienza, Rome, Italy.
During the last 2 decades, long-term survival after lung transplantation has significantly improved. However, among the complications related to the continuous administration of immunosuppressive drugs, malignancy plays an important role. We retrospectively revisited our series of patients to report our experience.
View Article and Find Full Text PDFEffects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
Clin Nephrol
July 2005
Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
Aim: Mizoribine (MZR) is a purine antimetabolic immunosuppressant agent that has few little severe adverse events. We studied whether maintenance therapy with MZR and prednisolone (PSL) in severe proliferative lupus nephritis patients could improve immunity, reduce proteinuria, prevent renal relapse, and reduce steroid dose.
Method: Long-term maintenance therapy with MZR and PSL was evaluated in ten patients with biopsy-proven proliferative lupus nephritis.
[Surgical management of pathologic filtering blebs in pediatric glaucoma].
Klin Oczna
March 2005
Kliniki Okulistyki Instytutu-Pomnika Centrum Zdrowia Dziecka.
The aim of this paper is to present our own experience in the treatment of cystic blebs in children and young adults. This complication, which is the most popular after trabeculectomy with antimetabolic agents, can be the reason of late endophthalmitis. Surgical treatment is one of the method to prevent it.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!